Committee Chairs
2012 Hope Ball Honorees
JDRF
Dana Germer Cristi Trusler
Past JDRF Austin Board Presidents
Christos Anagnos Gene Austin
Vicki Callegari
Past Honorees
Executive Director
2003 Liz & Kirk Watson
JDRF
Executive Team
2002 Debbie & Kevin Rollins
Kari Rouse
2004 Marnie & Dave Near
Special Events Manager
2005 Papermaster Family
Amy Hyman Development Manager
2006 Rachel & John Schuler 2007 Laura & Todd Templeton 2008 Austin mothers of children with type 1
Melissa Ray
Mary Cantrell, Laura Crumpacker, Cindy Goldrick,
Office Manager & Volunteer Coordinator
Cindy Salinas, Melissa Segrest, Nancy Stobaugh
Tristina Oppliger
and Jodi Zipp
Special Events Assistant
2009 Isabelle Carpenter, her brother Walker and parents Art and Alexandra Carpenter 2010 Walt Thirion
Kiley diagnosed at age 8
2011 Toni & Tim Clark Luke diagnosed at age 7
Board of Directors
Josh Alsup
Greg Bailes
JDRF
Research Funding Overview
• Since its founding in 1970, JDRF has funded more than $1.6 billion in T1D research and has dramatically advanced Maya diagnosed at age 3
Terry Browne
the T1D scientific frontier and the management of this disease. In FY2011 alone, JDRF provided more than $116 million for T1D research.
Darryl Crawford
• More than 80 percent of JDRF’s expenditures directly support research and research-related education.
Tracey Davies
JDRF maintains one of the best records among all non-profits for effective and efficient management of donor
Steve Dean
contributions.
Becca Dietz
• In FY2011, JDRF funded research projects in 18 countries representing the global scope of JDRF’s research efforts.
Mark Garrett
• As more JDRF programs move forward, the number of human or clinical studies has grown. In FY2011, JDRF
Tom Gentry
supported 53 clinical studies, including evaluations of new therapies, studies of the normal course of T1D, and
Betty Hewell
others to collect specific T1D human samples.
Beckie McCleery Jeff Needles
JDRF’s Research Goals
Morgan Stone
JDRF research is committed to improving the lives of every person with T1D and to curing this disease.
David Robshaw
JDRF’s research goals are realized by the projects being supported in three basic areas:
Ronnie Taylor
cure
Laura Templeton
Restoring a person’s insulin-producing capability and halting or reversing the body’s misguided immune attack on
Sharlyn Threadgill
the pancreas.
Dave Waller, President
treat
Mike Walker Todd Werner Valerie Wheelock, M.D. Rachel Wyatt
2012 Hope Ball A10 Invitation.indd 1-3
Morgan diagnosed at age 12
Developing new devices and therapies that optimize blood sugar control and treat or prevent the complications 3420 Executive Center Drive Suite 108 Austin, Texas 78731 Phone: 512.343.0663 Fax: 512.343.0773 www.jdrf.org/austin
of T1D.
prevent
Message of Hope Dedicated to Delivering the
and a Cure for type 1 diabetes
Type 1 diabetes is an autoimmune disease which strikes in childhood, adolescence, or adulthood, but lasts a lifetime. As many as 3 million Americans have type 1 diabetes. Approximately 80 people every day are diagnosed with type 1 diabetes in the U.S. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. JDRF is the world’s leading funder and advocate of type 1 diabetes science.
Preventing T1D from occurring or stopping the disease process before it damages the pancreas. Photography by Rala Imaging
J
D
R
F
J
D
R
F
J
J
D
R
F
J
D J
D D
R
F R
R
J F
F
D J
J
R
J
F
D
R
F
D
R
F
J
D
R
D
R
F
J
D
R
J
D
F F
J J
R D
D
J
F R
R
D J
F F
J
R D
D
F
J
R R
D
F F
J J
R D
D
J
F R
R
D J
F F
J
R D
D
F
J
R R
D
F F
J J
R D
D
F R
R
J
F F
J
D D
R R
F
J
D
R
F
F 3/26/12 2:43 PM